Global ipsen_lsmv_intake_prod@arisglobal.com Argélia pharmacovigilance.algeria@ipsen.com Austrália pharmacovigilance.australia@ipsen.com Áustria pharmacovigilance.germany@ipsen.com Bélgica pharmacovigilance.belgium@ipsen.com Brasil pharmacovigilance.brasil@ipsen.com Canadá pharmacovigilance.canada@ipsen.com China pharmacovigilance.china@ipsen.com Hong Kong – RPC pharmacovigilance.hongkong@ipsen.com Colômbia pharmacovigilance.colombia@ipsen.com República Checa pharmacovigilance.czech@ipsen.com Dinamarca pharmacovigilance.nordic@ipsen.com Finlândia pharmacovigilance.nordic@ipsen.com França pharmacovigilance.france@ipsen.com Alemanha pharmacovigilance.germany@ipsen.com Grécia pharmacovigilance.greece@ipsen.com Hungria pharmacovigilance.hungary@ipsen.com Irlanda pharmacovigilance.uk-ie@ipsen.com Itália pharmacovigilance.italy@ipsen.com Japão pv.japan@ipsen.com Cazaquistão pharmacovigilance.kazakhstan@ipsen.com Letônia pharmacovigilance.baltic@ipsen.com Lituânia pharmacovigilance.baltic@ipsen.com Luxemburgo pharmacovigilance.belgium@ipsen.com México pharmacovigilance.mexico@ipsen.com Holanda pharmacovigilance.netherlands@ipsen.com Noruega pharmacovigilance.nordic@ipsen.com Polônia pharmacovigilance.poland@ipsen.com Portugal pharmacovigilance.portugal@ipsen.com Romênia pharmacovigilance.romania@ipsen.com Federação Russa pharmacovigilance.russia@ipsen.com Singapura pharmacovigilance.sg@ipsen.com Eslováquia pharmacovigilance.slovakia@ipsen.com Coréia do Sul pharmacovigilance.korea@ipsen.com Espanha pharmacovigilance.spain@ipsen.com Suécia pharmacovigilance.nordic@ipsen.com Suiça pharmacovigilance.germany@ipsen.com Taiwan pharmacovigilance.taiwan@ipsen.com Tunísia pharmacovigilance.tunisie@ipsen.com Ucrânia pharmacovigilance.ukraine@ipsen.com Emirados Árabes Unidos pharmacovigilance.ksa@ipsen.com Reino Unido pharmacovigilance.uk-ie@ipsen.com Estados Unidos da América pharmacovigilance.usa@ipsen.com Vietnã pharmacovigilance.vietnam@ipsen.com